Recorded Webinar: Streamlining Collaborations and Drug Development using CDD Vault
Collaborative Drug
AUGUST 1, 2023
Streamlining Collaborations and Drug Development using CDD Vault and ELN
Drug Development Drugs Webinar 
Leveraging AI Solutions for Clinical Trial Efficiencies
PPD
JANUARY 15, 2025
As a result, drug developers make better decisions more quickly (removing 50% of study timeline whitespace) to bring new therapies to market faster. Watch our webinar The post Leveraging AI Solutions for Clinical Trial Efficiencies appeared first on PPD. Get in touch.
Join 15,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Revolutionizing Drug Development: AI Innovations in Healthcare
Fierce BioTech
MAY 21, 2024
png Listing Introduction Join us for an webinar on Revolutionizing Drug Development: AI Innovations in Healthcare, where you'll learn about the latest advancements in leveraging artificial intelligence to transform the drug development process. Listing Image AlphaSense_ListingLogo_250x190.png
How AI Accelerates Clinical & Drug Development Timelines
Fierce BioTech
JUNE 14, 2024
How AI Accelerates Clinical & Drug Development Timelines pesurya Fri, 06/14/2024 - 10:59 Wed, 09/11/2024 - 14:00 Resource Type Webinar Viswa Colluru, Ph.D. Optimizing and Accelerating Drug Discovery How can AI be utilized to obtain new biological insights and optimize chemical processes? Tony Cardozo Todd Rudo, M.D.
FDA welcomes alternative approaches to generic drug development
The Pharma Data
MAY 5, 2021
FDA officials said that the number of a product specific guidances (PSGs) issued by the Office of Generic Drugs (OGD) has increased steadily since FY 2013. FDA officials said that the number of a product specific guidances (PSGs) issued by the Office of Generic Drugs (OGD) has increased steadily since FY 2013. Source link.
Mini-Organs, Major Breakthroughs: How Hub Organoids Are Accelerating Oncology Drug Development
Fierce BioTech
APRIL 3, 2024
Mini-Organs, Major Breakthroughs: How Hub Organoids Are Accelerating Oncology Drug Development dwunderlin Wed, 04/03/2024 - 17:28 Tue, 05/14/2024 - 09:30 Resource Type Webinar Dr. Sylvia F. Boj Duration 60 Minutes Patient-derived organoids are viewed as the gold standard in bridging the gap between the lab and the clinic.
Webinar— A Square Peg in a Round Hole–Navigating the Unique Attributes of Psychedelic Drug Development
Alta Sciences
AUGUST 18, 2023
Webinar— A Square Peg in a Round Hole–Navigating the Unique Attributes of Psychedelic Drug Development iianiro Fri, 08/18/2023 - 19:49 URL [link] Description Save the date—Join us for a complimentary webinar for an overview of the draft FDA guidance on early-phase clinical development of psychedelics and how Altasciences can guide you through the process, (..)
Five Promising Treatment Areas in Early-Phase Drug Development in 2024
Alta Sciences
APRIL 17, 2024
Five Promising Treatment Areas in Early-Phase Drug Development in 2024 aasimakopoulos Wed, 04/17/2024 - 15:52 Early-phase drug development is an ever-changing landscape, as emerging science leads to new promising areas of research for the treatment of human health issues.
More than Just Words: Prioritizing Patient-Centered Drug Development
LifeSciVC
FEBRUARY 27, 2024
By Ivana Magovčević-Liebisch, CEO of Vigil Neuroscience, as part of the From The Trenches feature of LifeSciVC Patients and their care partners are at the center of our work in the life sciences industry – but at what point during the drug development process should companies start to engage these key stakeholders?
Webinar: Assessing Cognition Impairment Using Driving Simulators in Clinical Trials
Alta Sciences
FEBRUARY 8, 2024
The FDA guidance, Evaluating Drug Effects on the Ability to Operate a Motor Vehicle , indicates that testing in early-phase clinical development should emphasize sensitivity over specificity in CNS effects. In this on-demand webinar, Ingrid Holmes , Vice President of Global Clinical Operations at Altasciences, and Dr. Gary G.
Accelerating Global Drug Development Timelines With Ethnobridging
Alta Sciences
JUNE 9, 2023
Accelerating Global Drug Development Timelines With Ethnobridging rmaloney Mon, 06/12/2023 - 16:07 HTML Safe Strategy to Save Time and Money Avoid repeating Phase I studies for drugs intended for the Asian market. Download your copy today. In this complimentary webinar , Mel B. Watch the webinar.
[Webinar] How biotech companies can improve clinical supply planning and distrib…
The Pharma Data
SEPTEMBER 15, 2020
Find out solutions to mitigate the impact from clinical supply chain risk and discover how to improve dynamic drug supply forecasting strategies. Join this webinar to learn how supply forecasting and interactive response technology can help biotech companies improve supply planning and distribution while reducing cost and risk.
Harnessing AI and Real-World Data: The Future of Clinical Development
PPD
SEPTEMBER 16, 2024
The convergence of real-world data (RWD), technology and artificial intelligence (AI) is playing a vital role in accelerating drug development. In a recent panel discussion at DIA Global , our experts explored how these elements are reshaping clinical research and drug discovery.
Get a Head Start On Your 2024 Preclinical Drug Development Program
Alta Sciences
JANUARY 22, 2024
Get a Head Start On Your 2024 Preclinical Drug Development Program blussier Mon, 01/22/2024 - 15:18 HTML EXPERTISE Matters. With four strategically placed preclinical research facilities throughout North America, Altasciences can get your CTA/IND-enabling studies underway in just 8 weeks!
Developing and Manufacturing Minitablets to Extend Drug Lifecycle
Fierce BioTech
JANUARY 12, 2024
Developing and Manufacturing Minitablets to Extend Drug Lifecycle pesurya Fri, 01/12/2024 - 12:38 Wed, 02/28/2024 - 11:00 Resource Type Webinar Robert Strickley, PhD Valjon Demiri, MSc Duration 60 Minutes Oral minitablets can offer several advantages in pharmaceutical applications, making them a valuable option in drug delivery.
Drugs 
52
52 
Developing a New Drug Candidate: From Nonclinical to First-in-Human
Cytel
APRIL 3, 2024
Thank you to Charlotta Gauffin, Chief Scientific Officer at Dicot, for joining us for our recent webinar, “The Road to First-in-Human Trials: Insights from a Real-World Example.” Thoughtfully and carefully planned nonclinical studies help pave a smooth path toward first-in-human Phase 1 clinical trials.
From Bench to Bedside and Back Again: Strategies for Effectively Leveraging Pre-Clinical Data to Accelerate R&D
Fierce BioTech
JULY 17, 2023
Best practices for capturing reproducible and accurate in vivo data to reduce failure in clinical trials – the most expensive phase of drug development. Discussion will include: Current in vivo study management practices and processes. How did we get here?
6 Operational Considerations You Need To Know for Psychedelic Trials
Conversations in Drug Development Trends
OCTOBER 26, 2022
Having worked in psychedelic research since the advent of industry-sponsored trials, Worldwide Clinical Trials has amassed the expertise needed to execute these studies successfully, recently sharing insights in a webinar titled “ Demystifying Complex Operations in Psychedelic Research ,” available on-demand now. Check out the full webinar !
Trials 97
97 
Highlights From the Final ICH Drug Interactions Guideline
Fierce BioTech
SEPTEMBER 13, 2024
Highlights From the Final ICH Drug Interactions Guideline pesurya Fri, 09/13/2024 - 11:39 Thu, 10/31/2024 - 11:00 Resource Type Webinar Brian Ogilvie Graham Dyck Duration 60 Minutes The ICH M12 Guideline was finalized on May 21st, 2024, after extensive review of industry and other comments.
Drugs 52
52 
The Evolution of Oncology Trials: Project Optimus and Study Design Trends
Conversations in Drug Development Trends
JUNE 13, 2024
At Worldwide, Matt Cooper and Jim Eamma , our Executive Directors, Therapeutic Strategy Leads in Oncology, shed light on the intricacies of modern oncology trials in their recent webinar, “ Navigating the Landscape of Complex & Adaptive Oncology Trials.” How Does Project Optimus Impact Your Study’s Operations?
Trials 52
52 
Top 10 Life Science Resources for Summer 2024
Alta Sciences
JULY 25, 2024
39 Key Considerations for Nonclinical Dermal Studies—Advancing to Phase I An increasing number of advanced methods for dermal drug delivery can contribute to successful 505(b)(2) applications and extend the patent life of a drug for its sponsor. Watch the webinar. Watch the webinar. The Altascientist: Issue No.
Science 52
52 
Pharmacy Considerations for Early Phase Trials
Fierce BioTech
DECEMBER 23, 2024
First-in-Human, Drug-Drug Interaction, Food Effect, Bioequivalence, etc.), and often require consistent batches of drug product be administered to groups of research participants within a short timeframe, early phase studies present unique challenges for drug developers not typically experienced in later stages of development.
Pharmacy 52
52 
New modality - Peptides Innovations and A Comprehensive Synthetic Peptide Drug Discovery Platform
Fierce BioTech
MAY 1, 2024
BioDuro-Sundia has developed a comprehensive synthetic peptide discovery platform to help client in their drug discovery efforts. png Listing Introduction Join us on Monday, June 19, 2024 for one hour all about oral cyclic peptide drug development. Click here to login. Listing Image BioDuro_ListingLogo_250x190.png
Drugs 52
52 
Cognitive and Pharmacodynamic Testing in CNS First-In-Human Trials
Alta Sciences
JULY 22, 2024
Recently, we have seen increasing numbers of complex FIH studies in CNS-active drugs to gather comprehensive data with a wider range of doses as early as possible. jpg Tags Clinical Trials Weight 1
Trials 52
52 
Meet the Patient Advocate Panelists in Our Upcoming Webinar: Rare Disease Day 2023 Wrapped, What You Need to Take Away
Conversations in Drug Development Trends
FEBRUARY 22, 2023
Our rare disease team at Worldwide will be hosting a panel discussion webinar with patient advocates active in Rare Disease Day events to synthesize the most salient conversations taking place. See their conversation below and register for the webinar to hear more from these advocates!
Disease 52
52 
Insights from Industry Experts: Examining the Patient Experience in Clinical Trial Design
Conversations in Drug Development Trends
FEBRUARY 26, 2024
However, incorporating the patient experience into your design is one of the best ways to ensure your drug development program is a commercial success. In our recent Xtalks webinar, “ See How It’s Done: Case Studies on Patient Experience Design ,” our Therapeutic Strategy Lead, Rare Disease, Juliane K.
Are Gaps in Your Clinical Pharmacology Program Jeopardizing Your Drug’s Approval?
Fierce BioTech
OCTOBER 26, 2023
pesurya Thu, 10/26/2023 - 14:05 Tue, 12/05/2023 - 11:00 Resource Type Webinar Julie Bullock, PharmD Krithika Shetty, PhD Blaire Osborn, Ph.D. Eva Gil Berglund, PhD Justin Hay, PhD Paola Coppola, MSc Duration 60 Minutes Clinical pharmacology information comprises more than 50% of a drug label. Click here to login.
AI At The Frontier: Empowering Early Career Professionals In Drug Discovery
Elrig
APRIL 29, 2024
Webinar | Ai At The Frontier: Empowering Early Career Professionals In Drug Discovery WEBINAR – ARE YOU CURIOUS ABOUT THE CUTTING-EDGE INTERSECTION OF ARTIFICIAL INTELLIGENCE AND DRUG DISCOVERY? Are you curious about the cutting-edge intersection of Artificial Intelligence and Drug Discovery?
Advancing ADC development: Harnessing spatial biology and AI to develop targeted therapeutic strategies
Fierce BioTech
JANUARY 15, 2025
This powerful combination is providing the scientific community with unprecedented capabilities to tackle biological complexity and improve our understanding of the mechanisms underlying cancer development. Join us to learn how this technological convergence is reshaping the landscape of drug development and precision medicine.
Optimizing Formulation Strategies for Poorly Soluble Compounds: Insights into Bioavailability Enhancement and Accelerated Development
Fierce BioTech
JANUARY 3, 2025
Optimizing Formulation Strategies for Poorly Soluble Compounds: Insights into Bioavailability Enhancement and Accelerated Development dwunderlin Fri, 01/03/2025 - 15:54 Wed, 02/19/2025 - 11:00 Resource Type Webinar Feng Zhang, Ph.D. Hong Li, Ph.D.
Digital Strategies for Transforming Therapeutic Development in the 21st Century
Fierce BioTech
MARCH 5, 2025
In this webinar designed for biopharma digital leaders, we will share our insights and address the challenges biopharma companies face today.
Process Perfect Peptide Synthesis Combines Peptide and Normal Chemistry
Fierce BioTech
MAY 1, 2024
Join us on Monday, June 19, 2024 for one hour all about oral cyclic peptide drug development. With “specialized for peptide” drug metabolism and pharmacokinetics (DMPK) and biological evaluation, we’re able to solve certain synthesis issues found across different cyclic peptides, complexes peptides and mimetic peptides.
Organofluorine Chem in Pharma Intermediates & APIs
Fierce BioTech
SEPTEMBER 6, 2023
Organofluorine Chem in Pharma Intermediates & APIs swheeler Wed, 09/06/2023 - 12:54 Wed, 10/18/2023 - 11:00 Resource Type Webinar Dr. Yuanqiang Li Dr. Pete Newsome Peter Halkjaer-Knudsen Duration 60 minutes Topics Covered: Introduction to Organofluorine Chemistry and its significance in pharmaceuticals. Click here to login.
[Video] Watch and Smile – Our Canadian Team in Action
Alta Sciences
SEPTEMBER 29, 2023
You may also be interested in the following: • Webpage: CNS Drug Development Solutions • Scientific Journal: Challenges Associated with Schedule I Therapeutic Development • Webinar: Practical Approaches to Conducting Early Clinical Trials with Psychedelics Image 1280x720_ThinkCanada_Play.jpg Tags Clinical Trials Weight 10
AI Advancements in Life Sciences: Accelerating Innovation
Fierce BioTech
APRIL 4, 2024
Discover how leading organizations leverage AI to revolutionize operations and expedite drug development, ensuring faster access to life-saving treatments. Join our webinar: AI Advancements in Life Sciences: Accelerating Innovation. Listing Image Appian-LogoListing-9142023.png Register now!
Science 52
52 
Redefining Antibody Specificity Profiling for IND
Fierce BioTech
APRIL 10, 2024
Redefining Antibody Specificity Profiling for IND swheeler Wed, 04/10/2024 - 17:56 Thu, 06/06/2024 - 11:00 Resource Type Webinar Kris Raghavan, PhD Fernanda I. Staquicini, PhD Duration 60 minutes Assessment of antibody off-target reactivity is a regulatory requirement for clinical development. So, what are the alternatives?
The Future of Precision Medicine: Leveraging Clinico-Genomic Data for Germline Disorders
Fierce BioTech
MARCH 5, 2024
Genetic data combined with linked longitudinal clinical data, including full labs & patient vitals/demographics, has been shown to optimize target discovery and address the challenges of 'precision’ medicine development. Click here to login.
2024 FSP Trends, Strategies, and Projections
Fierce BioTech
MARCH 12, 2024
For biopharma and biotech companies, FSP partnerships have emerged as a pivotal strategy for accessing the complementary expertise and resource flexibility they need to meet their timelines, and innovative providers are implementing new, globalized FSP strategies to keep their clients ahead of the curve.
Tokenization: Leveraging Patient Health Data to Improve Care in a Meaningful, Sustainable Way
PPD
OCTOBER 16, 2023
Tokenization can accelerate innovation in clinical trials and drug development. Once in the data lake, tokenized data can be linked using a special linking software based on the data usage agreements to create longitudinal patient data. This enables deeper and more meaningful real-world insights on clinical study data.
When is the Right Time to Connect With a CDMO?
Alta Sciences
AUGUST 7, 2024
blussier Wed, 08/07/2024 - 19:51 HTML Timing is Everything Early collaboration with an experienced CDMO is crucial in drug development to mitigate manufacturing risks and ensure the efficient formulation of your API for preclinical and clinical testing. Contact us today to discuss the next stage of your drug development journey.
3 Key Takeaways from Psychedelic Science 2023
Conversations in Drug Development Trends
AUGUST 10, 2023
As psychedelic drugs move into clinical trials, we have an opportunity and responsibility to conduct ethically rigorous studies that encompass the experiences of a diverse and representative population. Worldwide has already made significant investments in diversity, equity, and inclusion, and we continually work to refine these efforts.
Science 98
98 
How to reach a fully integrated production environment by transforming labs
The Pharma Data
SEPTEMBER 9, 2020
We respect your privacy, by clicking “Download Your Copy” you will receive our e-newsletter, including information on Podcasts, Webinars, event discounts, online learning opportunities and agree to our User Agreement. Develop a fully automated environment to significantly boost research efforts.
Production 52
52 
New Findings on the Sinclair Nanopig™ in Safety Studies
Alta Sciences
SEPTEMBER 5, 2024
These findings validate this animal model as a valuable tool for regulatory pharmacology and drug safety, enhancing cross-species assessments and improving understanding of drug metabolism and potential toxicities. Read it now! WHITE PAPER Questions?
Process Chemistry Unleashed: A 'Fit-for-Purpose' Approach to Accelerate IND Filing
Fierce BioTech
JULY 27, 2023
Process Chemistry Unleashed: A 'Fit-for-Purpose' Approach to Accelerate IND Filing pesurya Thu, 07/27/2023 - 11:27 Tue, 09/05/2023 - 10:00 Resource Type Webinar Qixuan Lu Duration 60 Minutes Process chemistry plays a pivotal role in various stages of the pharmaceutical R&D cycle. Listing Image BioDuro_LogoListingNew_6142023.png
Let's personalize your content